Potassium: The Blood Pressure Mineral Most Americans Under-Consume

← Back to articles

The current National Academies Adequate Intake for potassium is 3,400 mg/day for adult men and 2,600 mg/day for adult women. The most recent NHANES estimates put median US intake at roughly 2,400–2,800 mg/day for men and 1,800–2,300 mg/day for women — a shortfall in essentially the entire population. Raising potassium intake has one of the largest blood-pressure effects of any nutritional change for people with hypertension.

What the trials and meta-analyses show

A WHO-commissioned BMJ meta-analysis pooled 22 randomised controlled trials (1,606 adult participants) and 11 cohort studies (127,038 adults). Higher potassium intake reduced systolic blood pressure by 3.49 mmHg (95% CI 1.82–5.15) and diastolic by 1.96 mmHg (95% CI 0.86–3.06) in adults with hypertension; the effect was not significant in normotensives. In observational data, higher potassium intake was associated with a 24% lower risk of stroke (RR 0.76, 95% CI 0.66–0.89), with no significant impact on renal function, blood lipids, or catecholamines (Aburto 2013; PMID 23558164; DOI 10.1136/bmj.f1378). The 2017 ACC/AHA hypertension guideline lists increasing dietary potassium to 3,500–5,000 mg/day as a non-pharmacologic Class IA recommendation for adults with elevated blood pressure (Whelton 2018; PMID 29133356).

Sodium and potassium act together

The sodium-to-potassium ratio may matter more than either nutrient alone. The Filippini 2021 dose-response meta-analysis of 85 sodium-reduction trials found an approximately linear drop in blood pressure across the entire range of sodium intake studied, with no flattening at low intakes and steeper effects in hypertensive participants (Filippini 2021; PMID 33586450; DOI 10.1161/CIRCULATIONAHA.120.050371). Stacking lower sodium with higher potassium reproduces the DASH diet pattern, which lowered systolic BP by 8–14 mmHg in hypertensive adults in the original DASH-Sodium trial.

Supplement safety caveats

Over-the-counter potassium supplements in the US are limited to 99 mg per tablet by FDA labelling guidance (driven by historical concerns about ulceration and cardiac arrhythmia from concentrated KCl tablets), so they contribute little to closing a multi-thousand-milligram gap. Prescription potassium chloride and potassium citrate (used for nephrolithiasis or hypokalaemia) are dosed at 10–40 mEq (780–3,120 mg) and are monitored with serum potassium. People taking ACE inhibitors, ARBs, potassium-sparing diuretics (spironolactone, eplerenone, amiloride), trimethoprim, or those with chronic kidney disease must not self-supplement potassium — hyperkalaemia can cause fatal arrhythmia. Potassium-based salt substitutes are similarly not safe for these groups.

Food-first strategy

Food sources outperform pills in essentially every trial because they deliver potassium with magnesium, fibre, and polyphenols at a slow absorption rate. Practical high-potassium foods: a baked potato with skin (~900 mg), one cup of cooked beans (~600 mg), a banana (~420 mg), one cup of cooked spinach (~840 mg), tomato sauce, prunes, salmon, plain yoghurt, and avocado. Adding one of these to most meals closes the gap quickly without the safety concerns of supplements.